AN ACT TO AUTHORIZE A PHARMACIST TO TEST OR SCREEN FOR AND INITIATE OR ADMINISTER TREATMENT FOR MINOR, NONCHRONIC HEALTH CONDITIONS; TO DEFINE THE TERM "MINOR, NONCHRONIC HEALTH CONDITION"; TO AUTHORIZE A PHARMACIST TO DELEGATE THE ADMINISTRATIVE AND TECHNICAL TASKS OF PERFORMING CERTAIN TESTS TO AN INTERN OR PHARMACY TECHNICIAN ACTING UNDER THE SUPERVISION OF THE PHARMACIST; TO AUTHORIZE A PHARMACIST TO PROHIBIT THE DENIAL OF REIMBURSEMENT UNDER HEALTH BENEFIT PLANS FOR SERVICES AND PROCEDURES PERFORMED BY A PHARMACIST THAT ARE WITHIN THE SCOPE OF THE PHARMACIST'S LICENSE, AND WOULD BE COVERED IF THE SERVICES OR PROCEDURES WERE PERFORMED BY A PHYSICIAN, AN ADVANCED PRACTICE REGISTERED NURSE, OR A PHYSICIAN ASSISTANT; TO AMEND SECTION 73-21-73, MISSISSIPPI CODE OF 1972, TO INCLUDE IN THE DEFINITION OF THE TERM "PRACTICE OF PHARMACY", ORDERING, PERFORMING AND INTERPRETING CERTAIN TESTS AND INITIATING, ADMINISTERING OR MODIFYING DRUG THERAPY; TO BRING FORWARD SECTION 83-9-36, MISSISSIPPI CODE OF 1972, WHICH RELATES TO PRESCRIBING PRACTITIONERS, STEP THERAPY OR FAIL-FIRST PROTOCOLS AND OVERRIDE PROCEDURES, FOR THE PURPOSE OF POSSIBLE AMENDMENT; AND FOR RELATED PURPOSES.
Impact
If implemented, SB2555 may transform the way minor health conditions are managed statewide. This could lead to increased efficiency in health service delivery, as patients could receive treatment directly from pharmacists without needing to visit a physician for minor ailments. Additionally, the bill establishes that health insurance plans cannot deny reimbursement for services rendered by pharmacists that are within the scope of their license, which aligns pharmacists’ services more closely with traditional healthcare providers like physicians and nurse practitioners.
Summary
Senate Bill 2555 introduces significant expansions to the role of pharmacists by allowing them to test, screen, and initiate treatment for selected minor, nonchronic health conditions. These conditions, as defined in the bill, range from influenza and streptococcus to more contemporary health issues like COVID-19 and other respiratory diseases. This legislative action aims to enhance access to immediate care through pharmacies, which is particularly vital in community health settings where timely intervention is necessary. By leveraging the expertise of pharmacists, the bill seeks to address health issues at their onset, potentially alleviating pressure on primary care providers and hospitals.
Contention
Some concerns may arise regarding this bill among healthcare professionals, particularly physicians, who might question the appropriateness of expanding pharmacists’ roles to include diagnosis and initiation of treatments for health conditions that may traditionally fall under their purview. There may also be apprehensions about the delegation of tasks to pharmacy technicians or interns, particularly concerning the quality and safety of care provided. Opponents of the bill might argue that this expansion could blur the lines between varied healthcare specialties and potentially complicate patient management if not properly regulated.
Relating to the regulation of pharmacists and the practice of pharmacy, including the administration of a medication and the ordering and administration of an immunization or vaccination by a pharmacist.